Recent DHR News
- Danaher Schedules First Quarter 2024 Earnings Conference Call • PR Newswire (US) • 03/21/2024 08:15:00 PM
- Danaher to Present at TD Cowen Health Care Conference • PR Newswire (US) • 02/27/2024 09:15:00 PM
- Danaher Commits to Set Science-Based, Net-Zero Greenhouse Gas Emission Reduction Targets • PR Newswire (US) • 02/22/2024 09:15:00 PM
- Danaher Announces Quarterly Dividend • PR Newswire (US) • 02/21/2024 09:15:00 PM
- Danaher Launches Collaboration with Cincinnati Children's Hospital Medical Center Aiming to Improve Patient Safety in Early Drug Development • PR Newswire (US) • 02/05/2024 12:30:00 PM
- Danaher Reports Fourth Quarter and Full Year 2023 Results • PR Newswire (US) • 01/30/2024 11:00:00 AM
- Danaher, Jennifer Doudna, and Innovative Genomics Institute Launch Danaher-IGI Beacon for CRISPR Cures with Aim to Address Hundreds of Diseases Using Gene-editing Platform Solution • PR Newswire (US) • 01/09/2024 12:30:00 PM
- Danaher Says 4Q Adjusted. Revenue to Fall by Less Than Forecast • Dow Jones News • 01/08/2024 09:57:00 PM
- Danaher CEO to Comment on Financial Performance • PR Newswire (US) • 01/08/2024 09:15:00 PM
- Danaher to Present at J.P. Morgan Healthcare Conference • PR Newswire (US) • 01/02/2024 10:00:00 PM
- Danaher Schedules Fourth Quarter 2023 Earnings Conference Call • PR Newswire (US) • 12/21/2023 09:30:00 PM
- Codexis and Aldevron Enter Exclusive Licensing Agreement for Codex® HiCap RNA Polymerase • GlobeNewswire Inc. • 12/13/2023 09:06:00 PM
- Danaher Completes Acquisition of Abcam • PR Newswire (US) • 12/06/2023 12:30:00 PM
- Danaher Cuts Quarterly Dividend to 24 Cents • Dow Jones News • 12/05/2023 10:14:00 PM
- Danaher Announces Quarterly Dividend • PR Newswire (US) • 12/05/2023 09:30:00 PM
- Danaher to Present at Evercore ISI HealthCONx Conference • PR Newswire (US) • 11/21/2023 09:15:00 PM
- Danaher on Track for Largest Percent Increase in Almost a Year -- Data Talk • Dow Jones News • 11/21/2023 07:22:00 PM
- Danaher appoints Christopher Riley to Executive Vice President for Biotechnology • PR Newswire (US) • 10/31/2023 11:30:00 AM
- Danaher 3Q Earnings, Sales Decline but Beat Estimates • Dow Jones News • 10/24/2023 10:41:00 AM
- Danaher Reports Third Quarter 2023 Results • PR Newswire (US) • 10/24/2023 10:00:00 AM
- Keep An Eye Out: Pre-Market Movers And Analyst Recommendations • IH Market News • 10/17/2023 10:34:10 AM
- Danaher Corporation Completes Separation of Veralto Corporation • PR Newswire (US) • 09/30/2023 12:00:00 PM
- Veralto Set to Join S&P 500; Vestis to Join S&P MidCap 400; Others to Join S&P SmallCap 600 • PR Newswire (US) • 09/28/2023 10:17:00 PM
- Danaher Schedules Third Quarter 2023 Earnings Conference Call • PR Newswire (US) • 09/26/2023 08:15:00 PM
- Danaher to Provide Cepheid's Tuberculosis Test to the Global Fund at Cost • PR Newswire (US) • 09/19/2023 11:43:00 AM
Endexx Corporation (EDXC) Leverages Global Market Trends and Legislative Reforms to Spearhead Growth in the Cannabis and Plant-Based Wellness Sectors • EDXC • Mar 27, 2024 3:01 PM
Applied UV, Inc. Announces Pricing of $2.76 Million Registered Direct and Private Placement Priced at the Market Under Nasdaq Rules • AUVI • Mar 27, 2024 2:51 PM
POET and MultiLane Collaborate to Develop High-Speed Pluggable Transceivers for AI Networks • POET • Mar 27, 2024 10:52 AM
Maybacks Global Entertainment Opens 23 More Stations in Important Major Cities • AHRO • Mar 27, 2024 9:00 AM
NxGen Brands Inc. Forecast to Deliver 140% Growth in Q1 2024 • NXGB • Mar 27, 2024 7:30 AM
Kona Gold Beverages, Inc. Strategic Advancements: Covert LLC Introduces Federally Legal D9 Gummies and Revamps Innovative eCommerce Platform, Propelling Toward $12 Million Annual Revenue Goal • KGKG • Mar 26, 2024 8:30 AM